Ann Hynes
Stock Analyst at Mizuho
(4.28)
# 388
Out of 4,937 analysts
258
Total ratings
61.83%
Success rate
10.77%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Outperform | $328 → $510 | $431.48 | +18.20% | 3 | Jul 25, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $190 → $225 | $179.86 | +25.10% | 13 | Jul 25, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $173 → $225 | $158.44 | +42.01% | 16 | Jul 25, 2025 | |
| THC Tenet Healthcare | Maintains: Outperform | $184 → $194 | $165.58 | +17.16% | 15 | Jul 11, 2025 | |
| MOH Molina Healthcare | Maintains: Outperform | $400 → $330 | $156.90 | +110.33% | 9 | Jul 11, 2025 | |
| FTRE Fortrea Holdings | Maintains: Neutral | $8 → $7 | $6.58 | +6.46% | 4 | Jul 11, 2025 | |
| CNC Centene | Maintains: Neutral | $71 → $40 | $25.59 | +56.31% | 8 | Jul 11, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $515 → $350 | $250.89 | +39.50% | 18 | May 16, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $37 → $32 | $19.24 | +66.32% | 11 | May 14, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $178 → $189 | $176.96 | +6.80% | 15 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $305 → $316 | $266.68 | +18.49% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $455 → $505 | $293.99 | +71.77% | 4 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $155 | $148.74 | +4.21% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $76 | $65.54 | +15.96% | 10 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $18 | $11.89 | +51.39% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $14.33 | +4.68% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $157.41 | -23.77% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $20.78 | -3.75% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $21.62 | +29.51% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $117.58 | -19.20% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $274.90 | +40.05% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $172.30 | +16.08% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.84 | +14,465.22% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $668.58 | -24.47% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $265.85 | -13.49% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $381.61 | -27.94% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $31 → $25 | $11.94 | +109.38% | 8 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $23.67 | +111.24% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.50 | +3,700.00% | 1 | Sep 21, 2017 |
Medpace Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $328 → $510
Current: $431.48
Upside: +18.20%
IQVIA Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $179.86
Upside: +25.10%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $158.44
Upside: +42.01%
Tenet Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $184 → $194
Current: $165.58
Upside: +17.16%
Molina Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $400 → $330
Current: $156.90
Upside: +110.33%
Fortrea Holdings
Jul 11, 2025
Maintains: Neutral
Price Target: $8 → $7
Current: $6.58
Upside: +6.46%
Centene
Jul 11, 2025
Maintains: Neutral
Price Target: $71 → $40
Current: $25.59
Upside: +56.31%
UnitedHealth Group
May 16, 2025
Maintains: Outperform
Price Target: $515 → $350
Current: $250.89
Upside: +39.50%
Acadia Healthcare Company
May 14, 2025
Maintains: Neutral
Price Target: $37 → $32
Current: $19.24
Upside: +66.32%
Quest Diagnostics
Apr 9, 2025
Maintains: Outperform
Price Target: $178 → $189
Current: $176.96
Upside: +6.80%
Apr 9, 2025
Maintains: Outperform
Price Target: $305 → $316
Current: $266.68
Upside: +18.49%
Apr 9, 2025
Maintains: Outperform
Price Target: $455 → $505
Current: $293.99
Upside: +71.77%
Apr 9, 2025
Maintains: Neutral
Price Target: $175 → $155
Current: $148.74
Upside: +4.21%
Apr 9, 2025
Maintains: Outperform
Price Target: $70 → $76
Current: $65.54
Upside: +15.96%
Apr 9, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $11.89
Upside: +51.39%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $14.33
Upside: +4.68%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $157.41
Upside: -23.77%
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $20.78
Upside: -3.75%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $21.62
Upside: +29.51%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $117.58
Upside: -19.20%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $274.90
Upside: +40.05%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $172.30
Upside: +16.08%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.84
Upside: +14,465.22%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $668.58
Upside: -24.47%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $265.85
Upside: -13.49%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $381.61
Upside: -27.94%
Oct 10, 2023
Maintains: Neutral
Price Target: $31 → $25
Current: $11.94
Upside: +109.38%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $23.67
Upside: +111.24%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.50
Upside: +3,700.00%